Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prehospital fibrinogen concentrate for acute traumatic haemorrhage
ACTRN12623000812695Phase 2Recruiting
- Sponsor
- NSW Ambulance
- Start
- Dec 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Fibrinogen human in Bleeding, sponsored by NSW Ambulance. Primary endpoint: Fibrinogen response on hospital arrival. Started Dec 2023; status: recruiting.
02
Drugs
Fibrinogen human
03
Conditions
Bleeding
Beyond the preview
Go deeper on ACTRN12623000812695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000812695.